Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 38.29 | 44.76 | 37.94 | 0.65 |
Short Term Investments | 10.75 | 3.43 | 0.80 | 1.14 |
Cashand Short Term Investments | 49.05 | 48.19 | 63.82 | 6.48 |
Accounts Receivable- Trade Net | 69.85 | 84.40 | 57.18 | 90.74 |
Total Receivables Net | 72.20 | 86.07 | 69.45 | 92.65 |
Total Inventory | 152.77 | 162.50 | 169.96 | 72.02 |
Other Current Assets Total | 23.89 | 15.49 | 130.26 | 11.60 |
Total Current Assets | 297.91 | 312.25 | 435.89 | 184.25 |
Property/ Plant/ Equipment Total- Net | 503.07 | 426.52 | 210.79 | 130.16 |
Intangibles Net | 0.35 | 0.48 | 0.32 | 0.10 |
Long Term Investments | 4.26 | 2.66 | - | - |
Other Long Term Assets Total | 13.13 | 16.95 | 11.31 | 0.30 |
Total Assets | 818.72 | 758.86 | 658.30 | 314.80 |
Accounts Payable | 45.03 | 32.19 | 44.51 | 47.48 |
Current Portof LT Debt/ Capital Leases | 13.63 | 166.03 | 14.36 | 14.19 |
Other Currentliabilities Total | 21.00 | 40.48 | 13.61 | 7.05 |
Total Current Liabilities | 79.66 | 238.69 | 171.43 | 118.02 |
Long Term Debt | 0.64 | 4.23 | 11.09 | 24.13 |
Total Long Term Debt | 0.64 | 4.23 | 13.11 | 26.76 |
Total Debt | 14.27 | 170.26 | 119.94 | 90.25 |
Other Liabilities Total | 1.33 | 1.15 | 0.67 | 1.98 |
Total Liabilities | 81.64 | 244.07 | 185.21 | 148.84 |
Common Stock Total | 23.39 | 22.17 | 22.17 | 20.09 |
Retained Earnings( Accumulated Deficit) | 713.69 | 492.63 | 241.28 | 145.60 |
Total Equity | 737.08 | 514.79 | 473.09 | 165.96 |
Total Liabilities Shareholders' Equity | 818.72 | 758.86 | 658.30 | 314.80 |
Total Common Shares Outstanding | 2.34 | 2.22 | 2.22 | 2.22 |
Tangible Book Valueper Share Common Eq | 314.95 | 232.04 | 213.30 | 74.83 |
Cash | - | - | 25.08 | 4.69 |
Prepaid Expenses | - | - | 2.40 | 1.51 |
Property/ Plant/ Equipment Total- Gross | - | - | 185.50 | - |
Accumulated Depreciation Total | - | - | -26.21 | - |
Accrued Expenses | - | - | 6.48 | - |
Notes Payable/ Short Term Debt | - | - | 92.47 | 49.29 |
Capital Lease Obligations | - | - | 2.02 | 2.64 |
Deferred Income Tax | - | - | 0.00 | 2.08 |
Additional Paid- In Capital | - | - | 209.03 | - |
Other Equity Total | - | - | 0.62 | 0.27 |
Tatva Chintan Pharma Chem Dividend Tatva Chintan Pharma Chem Bonus Tatva Chintan Pharma Chem News Tatva Chintan Pharma Chem AGM Tatva Chintan Pharma Chem Rights Tatva Chintan Pharma Chem Splits Tatva Chintan Pharma Chem Board Meetings Tatva Chintan Pharma Chem Key Metrics Tatva Chintan Pharma Chem Shareholdings Tatva Chintan Pharma Chem Profit Loss Tatva Chintan Pharma Chem Cashflow Tatva Chintan Pharma Chem Q1 Results Tatva Chintan Pharma Chem Q2 Results Tatva Chintan Pharma Chem Q3 Results Tatva Chintan Pharma Chem Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks